pRESET for Occlusive Stroke Treatment

NACompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

October 4, 2019

Primary Completion Date

May 12, 2022

Study Completion Date

May 12, 2022

Conditions
Brain DiseasesCardiovascular DiseasesCentral Nervous System DiseasesCerebrovascular DisordersIschemiaNervous System DiseasesPathologic ProcessesStroke, IschemicStroke, AcuteVascular Diseases
Interventions
DEVICE

Mechanical Thrombectomy using the pRESET Thrombectomy device

Clot removal using the pRESET Thrombectomy device

DEVICE

Mechanical Thrombectomy using the Solitaire Revascularization Device

Clot removal using the Solitaire Revascularization Device

Trial Locations (24)

10016

NYU Langone Health, New York

10029

The Mount Sinai Hosptial, New York

10467

Montefiore Medical Center, The Bronx

14203

Buffalo General Medical Center, Buffalo

15213

UPMC, Pittsburgh

23562

Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck

28205

Klinikum Bremen-Mitte, Bremen

30322

Grady Memorial Hospital, Atlanta

32207

Baptist Health Research Institute Jacksonville, Jacksonville

33146

University of Miami, Coral Gables

43214

OhioHealth Research Institute, Columbus

52242

University of Iowa Hospitals and Clinics, Iowa City

60515

Advocate Lutheran General Hospital, Downers Grove

60612

Rush University Medical Center, Chicago

69120

Universitätsklinikum Heidelberg, Heidelberg

78550

Valley Baptist, Harlingen

81675

Klinikum rechts der Isar Technische Universität München, München

85251

Honor Health Research Institute, Scottsdale

90404

Providence Little Company of Mary Medical Center, Santa Monica

97239

Oregon Health & Science University, Portland

98122

Swedish Medical Center - Cherry Hill Campus, Seattle

99089

Helios Klinikum Erfurt GmbH, Erfurt

01655

University of Massachusetts, Worcester

08820

JFK Medical Center, Edison

All Listed Sponsors
lead

phenox Inc.

INDUSTRY

NCT03994822 - pRESET for Occlusive Stroke Treatment | Biotech Hunter | Biotech Hunter